Purpose of the group
Support for innovation in life sciences is critical for the development of Scotland’s future economic success, together with strategies for the practical applications which improve the health and lives of millions of people globally.
The Cross-Party Group will be the forum for Members of the Scottish Parliament (MSPs), stakeholders and interested parties to engage directly with each other in order to raise awareness of the opportunities and challenges facing the sector and to better inform the development of policy in this important area.
Forthcoming meetings
Next meeting:
Group Officers
Group Members
Non MSP Individuals
Peter J B Shakeshaft
Grant Sellar, D.Phil
Michael J. Butler, Ph.D
Bill MacNee
Professor Grahame Bulfield
Lubna Kerr
Jacquie Forde
Alan J Muir
Janice Johnson
Marc Turner
Leo James
Professor David Wyper
Organisations
Association of the British Pharmaceutical Industry
BioIndustry Association Scotland
Medical Devices Scotland
Wyeth Pharmaceuticals
University of Glasgow.
AstraZeneca UK Limited
Hudson, Edinburgh.
Scottish National Blood Service
Aptuit (Edinburgh) Ltd
INTERFACE
University of Edinburgh.
University of Aberdeen.
Diabetes UK Scotland
Dynamic Earth Enterprises Ltd
Telehealth Solution Ltd
Scottish Enterprise
CXR Biosciences
Doherty Innovation Centre
Advanced Biosystems/Biobest Laboratories Ltd.
SSCN Ltd, Edinburgh
Napier University.
Glasgow Royal Infirmary
Preclinical Europe, Preclinical Services
University of Dundee.
College of Science and Engineering, Edinburgh
Scottish Funding Council
Life Sciences, Targeting Innovation Ltd
Controlled Therapeutics Ltd
BIA Scotland
Strathclyde University
Royal Society of Edinburgh
ITI Life Sciences
Adel Consulting Ltd
AstraZeneca
Economic Projects
Strathclyde Institute of Pharmacy and Biomedical Sciences
Scottish Centre for Telehealth
Pfizer
Moredun Research Institute
Meningitis Trust
GSK
Scottish Lifesciences Association
Get involved
Next meeting:
Contact:
Tel: